All the news Showing 10 of 29 articles from: CoronavirusGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources COVID-19 pandemic led to a 30% drop in new hepatitis C treatments in the United States Keith Alcorn / 22 March 2022 Hepatitis C testing and treatment initiations in the United States dropped by 30% at the beginning of the COVID-19 pandemic in 2020 and treatment initiations did not recover to previous levels during ... COVID-19 vaccine protection is ‘lower and slower’ in people with cirrhosis Keith Alcorn / 22 November 2021 People with cirrhosis of the liver may take longer to achieve protection from SARS-CoV-2 and severe COVID-19 after vaccination, according to large studies in the United States and Chile, presented earlier this month ... People with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines Keith Alcorn / 16 November 2021 People with cirrhosis of the liver had delayed and suboptimal responses to the Pfizer or Moderna SARS-CoV-2 vaccines compared to healthy adults, an Italian study has found. People with decompensated cirrhosis had significantly ... Treatment for hepatitis B and C fell in 2020 due to COVID-19, global survey finds Keith Alcorn / 16 November 2021 Viral hepatitis tests and treatment declined significantly during 2020 as a consequence of the COVID-19 pandemic, a survey of 31 liver centres on five continents has shown. The decline in testing and ... Testing COVID-19 patients for viral hepatitis does not detect numerous undiagnosed cases Keith Alcorn / 19 September 2021 Screening people admitted to hospital with COVID-19 for hepatitis C or hepatitis B does not lead to detection of a large number of undiagnosed infections and is likely to be of limited ... US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Keith Alcorn / 16 August 2021 People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ... COVID-19 vaccine responses are weaker in liver transplant patients Keith Alcorn / 08 July 2021 Liver transplant recipients in Israel were less likely to develop antibodies after a second dose of the Pfizer SARS-CoV-2 vaccine than healthy volunteers, transplant specialists from Tel Aviv’s Sourasky Medical Center report in ... Weaker COVID-19 vaccine responses seen in people with advanced liver fibrosis Liz Highleyman / 05 July 2021 Among people with non-alcoholic fatty liver disease (NAFLD), those with more advanced liver fibrosis did not respond as well to the Pfizer-BioNTech COVID-19 vaccine, according to study results presented at the 2021 International ... Advanced cirrhosis or alcohol use disorder raised the risk of COVID-19 death in France Keith Alcorn / 25 June 2021 People with advanced cirrhosis or alcohol use disorder were significantly more likely to die from COVID-19 in France during 2020 compared to the rest of the population, a study of the French ... Antiviral treatments for hepatitis B may reduce severity of COVID-19 or risk of infection Keith Alcorn / 25 June 2021 People taking tenofovir (Viread) as treatment for hepatitis B were significantly less likely to suffer severe COVID-19 or to need mechanical ventilation after admission to hospital than people taking the alternative hepatitis B ... ← First123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive